A detailed history of Visionary Wealth Advisors transactions in Astrazeneca PLC stock. As of the latest transaction made, Visionary Wealth Advisors holds 4,116 shares of AZN stock, worth $265,235. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,116
Previous 4,126 0.24%
Holding current value
$265,235
Previous $321,000 0.31%
% of portfolio
0.02%
Previous 0.02%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$76.67 - $87.62 $766 - $876
-10 Reduced 0.24%
4,116 $320,000
Q1 2024

May 15, 2024

SELL
$61.03 - $69.57 $28,378 - $32,350
-465 Reduced 10.13%
4,126 $279,000
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $49,512 - $55,424
800 Added 21.1%
4,591 $309,000
Q2 2023

Aug 11, 2023

SELL
$69.91 - $75.81 $6,711 - $7,277
-96 Reduced 2.47%
3,791 $271,000
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $1,010 - $1,145
16 Added 0.41%
3,887 $269,000
Q4 2022

Feb 13, 2023

SELL
$54.21 - $70.44 $1,138 - $1,479
-21 Reduced 0.54%
3,871 $262,000
Q3 2022

Nov 14, 2022

BUY
$53.02 - $135.75 $1,113 - $2,850
21 Added 0.54%
3,892 $213,000
Q2 2022

Aug 12, 2022

SELL
$59.26 - $71.14 $7,111 - $8,536
-120 Reduced 3.01%
3,871 $256,000
Q4 2021

Feb 14, 2022

BUY
$54.02 - $63.83 $215,593 - $254,745
3,991 New
3,991 $232,000
Q3 2021

Nov 12, 2021

SELL
$55.56 - $60.79 $235,907 - $258,114
-4,246 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$48.42 - $60.18 $73,888 - $91,834
-1,526 Reduced 26.44%
4,246 $254,000
Q1 2021

May 18, 2021

BUY
$47.16 - $54.44 $4,716 - $5,444
100 Added 1.76%
5,772 $287,000
Q4 2020

Feb 16, 2021

BUY
$48.52 - $58.02 $275,205 - $329,089
5,672 New
5,672 $284,000
Q3 2020

Nov 16, 2020

SELL
$53.07 - $61.1 $203,576 - $234,379
-3,836 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$43.1 - $55.31 $165,331 - $212,169
3,836 New
3,836 $203,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Visionary Wealth Advisors Portfolio

Follow Visionary Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Visionary Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Visionary Wealth Advisors with notifications on news.